Multiple Ascending Dose Study of DW4421

NCT07691242 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Volunteers

Interventions

DRUG: DW4421S-T0
DRUG: DW4421S-T2
DRUG: DW4421S-T1
DRUG: DW4421S-T3
DRUG: DW4421S
DRUG: DW4421-3

Sponsor

Daewon Pharmaceutical Co., Ltd.